Lipid [lipd]
Lipoprotein [aapp, bacs]
Profile [lbpr]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Low dose [qnco]
Combinations [mnob]
17 beta-Estradiol [horm, phsu, strd]
Norethisterone [horm, phsu, strd]
Acetate [orch, phsu]
Objective [inpr]
Evaluate [ftcn]
Modification [ftcn]
Lipid [lipd]
Lipoprotein [aapp, bacs]
Low dose [qnco]
Continuous [idcn]
Combined [qlco]
Formulation [resa]
17beta estradiol [horm, phsu, strd]
Norethisterone acetate [horm, phsu, strd]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Design [acty]
Study [mnob]
Design [acty]
DOUBLE BLIND [resa]
randomized [resa]
placebo-controlled [resa]
Trial [resa]
Health [idcn]
postmenopausal [tmco]
Women [popg]
randomized [resa]
Treatment Arm [resa]
placebo [topp]
Group [idcn]
N NOS [aapp, imft]
Norethisterone acetate [horm, phsu, strd]
mg% [qnco]
Group [idcn]
Subject [grup]
Receive [qlco]
Oral [spco]
Continuous [idcn]
Combined [qlco]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
mg% [qnco]
N NOS [aapp, imft]
E2 [gngm]
norethindrone acetate 0.5 MG [clnd]
Group [idcn]
Women [popg]
treated [topp]
E-1 [moft]
mg% [qnco]
norethindrone acetate 0.5 MG [clnd]
N NOS [aapp, imft]
Duration [tmco]
Study [mnob]
months [tmco]
Plasma [bdsu]
Total Cholesterol [lbpr]
Low density lipoprotein [aapp, bacs, lipd]
High density lipoprotein [aapp, bacs, lipd]
Very low density lipoprotein cholesterol [bacs, strd]
Triglycerides [bacs, lipd]
Lipoprotein (a) [aapp, bacs]
Apolipoprotein A [aapp, bacs]
Apolipoprotein B [aapp, bacs]
Occasional [tmco]
i e [diap, inpr]
baseline [bodm]
Visits [bhvr]
baseline [bodm]
Characteristics [qlco]
Group [idcn]
Women [popg]
COMPLETED [qlco]
Study [mnob]
Compliance [qnco]
reduction [npop]
Total Cholesterol [lbpr]
Cholesterol, LDL [bacs, strd]
Lipoprotein (a) [aapp, bacs]
Combined [qlco]
Group [idcn]
Compared [acty]
placebo [topp]
Apolipoprotein B [aapp, bacs]
Norethisterone acetate [horm, phsu, strd]
mg% [qnco]
Group [idcn]
Observed [ftcn]
3 Months [tmco]
treatment [ftcn]
Maintained [ftcn]
Triglycerides [bacs, lipd]
Very low density lipoprotein cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Apolipoprotein A [aapp, bacs]
High density lipoprotein [aapp, bacs, lipd]
Ratio [qnco]
Active [ftcn]
Combined [qlco]
Group [idcn]
statistically significant [qnco]
Note [clna]
Favorable [qlco]
Lipids [lipd]
Lipoproteins [aapp, bacs]
Low dose [qnco]
Norethisterone acetate [horm, phsu, strd]
Combinations [mnob]
effects [qlco]
Contribute [acty]
reduction [npop]
Prevention [topp]
Atherogenesis [patf]
postmenopausal [tmco]
Women [popg]
